SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
902 9 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
202The NeuroBioPharm warrents expire in April. Have you done anything with these iThe Ox-2/6/2014
201Technical Alert Symbol Exchange Name Event Close at Event Target Price RangSultan11/23/2014
200Good interview.. Professional Investor Explains His 2 Largest Healthcare HoldiSultan11/22/2014
199Neptune Erecting A Moat In Omega-3; Shares Undervalued seekingalpha.comSultan-1/21/2014
198Conference Call - discussing 3rd Qtr. results and future direction .. media-seSultan11/15/2014
197Neptune Reports Third Quarter Results and Provides Update on Action Plan to ResuSultan11/14/2014
196ACST down 11% in the premarket.....here's the earnings release: finance.yahThe Ox-1/14/2014
195Nice response by NEPT stock price to the SA article. Especially in a down markeThe Ox-1/13/2014
194Neptune to Hold Conference Call to Discuss Third Quarter Results LAVAL, Quebec,Sultan-1/13/2014
193Over the next 3 years, if ACST or NEPT can get anywhere near his valuation targeThe Ox-1/11/2014
192While Amarin Continues To Go Rancid, Neptune Will Soar seekingalpha.comSultan-1/11/2014
191FDA Clears Acasti's Investigational New Drug Submission to Conduct PK Trial Sultan11/9/2014
190Neptune Receives New Food Raw Material Certification in China LAVAL, Quebec, JaSultan11/9/2014
189We added a bit in the 2.50 range and would have added a lot more if it hit the 2The Ox-12/18/2013
188Right.. If these are all resolved, they can concentrate on execution.. New PlanSultan-12/18/2013
187I like that these issues are being settled. They have been a cloud over NEPT. The Ox-12/18/2013
186Neptune, Acasti and Enzymotec Sign Settlement Term Sheet Resulting in Stay of ITSultan112/18/2013
185Neptune and Aker BioMarine Reach Patent Infringement Settlement and License AgreSultan112/17/2013
184Top 10 Nasdaq-traded stocks posting largest volume increases NEW YORK (AP) -- ASultan-12/14/2013
183Acasti Pharma: 7 Different Insiders Have Purchased Shares This Month seekingalpSultan-12/10/2013
182Acasti Announces Closing of US$23 Million Underwritten Offering of Units financSultan-12/3/2013
181Acasti Completes PK IND Submission finance.yahoo.comSultan-11/11/2013
180Acasti Strengthens Its IP Portfolio US Patent Application Allowed by USPTO and Sultan-10/29/2013
179JMP Securities comment on NEPT and ACST--maintaining $7 sum-of-parts valuation (Sultan-10/17/2013
178CC Audio.. media-server.comSultan-10/17/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News